Somatic Cell Differentiation Reagent for Alveolar Epithelial Cells

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for obtaining alveolar epithelial cells from stem cells are time-consuming and labor-intensive, and using stem cells for transplantation can lead to tumor formation, making clinical application difficult.

Innovation Solution

A reagent and method using NK2 homeobox family, Fox family, and Gata family gene expression vectors to differentiate somatic cells, such as fibroblasts, into alveolar epithelial cells, with optional inclusion of a Gata Binding Protein 6 gene, and culturing in the presence of dexamethasone and Fibroblast Growth Factor proteins for efficient differentiation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If stem cells are used to obtain alveolar epithelial cells, then the cells can be obtained through differentiation, but the process is time-consuming and labor-intensive

Engineering Contradiction:

Improveability to obtain alveolar epithelial cellsVSAvoidtime required for differentiation process

Core Design Contradiction:

ReliabilityVSLoss of time

Solution Approach 1:

The patent applies preliminary action by pre-construction of the differentiation pathway through forced expression of key transcription factors (Nkx2-1, Foxa1/2, Gata6) in somatic cells. This pre-programming of the differentiation program allows cells to directly transition to alveolar epithelial cells without requiring the lengthy natural differentiation process that stem cells undergo, thereby significantly reducing the time required while maintaining the ability to obtain functional alveolar epithelial cells

Inventive Principle:

Principle #10Preliminary action

2Reliability

If stem cells are used for transplantation, then regeneration of lung cells is possible, but tumors such as teratoid tumors may be formed

Engineering Contradiction:

Improveregenerative abilityVSAvoidtumor formation risk

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies the taking out principle by extracting and isolating only the essential differentiation-determining genes (Nkx2-1, Foxa1/2, Gata6) from the complex stem cell system. By forcing expression of only these specific transcription factors in somatic cells, the invention achieves targeted differentiation into alveolar epithelial cells without involving the full pluripotent potential of stem cells, thereby eliminating the risk of teratoma formation while preserving the regenerative capability

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses somatic cells (fibroblasts, keratinocytes) that are readily available and have limited proliferative capacity compared to stem cells. These somatic cells serve as a safe, disposable starting material that cannot form teratomas due to their restricted differentiation potential, yet can be efficiently converted to alveolar epithelial cells through forced expression of key transcription factors

Inventive Principle:

Principle #27Cheap short-living objects (Disposable)

3Ease of manufacture

If a simple differentiation method is used, then clinical application becomes feasible, but the differentiation efficiency may be insufficient

Engineering Contradiction:

Improvesimplicity of differentiation methodVSAvoiddifferentiation efficiency

Core Design Contradiction:

Ease of manufactureVSProductivity

Solution Approach 1:

The patent applies merging by combining multiple key transcription factors (Nkx2-1, Foxa1/2, Gata6) into a single forced expression system. This consolidation of multiple differentiation-determining genes into one integrated approach simplifies the manufacturing process compared to traditional multi-step differentiation protocols, while simultaneously achieving high differentiation efficiency through the synergistic action of these transcription factors working together in the somatic cells

Inventive Principle:

Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the simpler and more efficient production of alveolar epithelial cells without the need for stem cells, reducing the risk of tumor formation and facilitating clinical application.

Implementation Method 1

a reagent for differentiating somatic cells into alveolar epithelial cells, the reagent including an NK2 homeobox family gene expression vector, and a Fox family gene expression vector

Methodology Applied

Scientific EffectGene expression:

Implementation Method 2

the culturing step is performed in the presence of dexamethasone and a Fibroblast Growth Factor (FGF) family protein

Methodology Applied

Scientific EffectHormonal signaling:

Data Source

PatentUS11718831B2Reagent for differentiating somatic cells into alveolar epithelial cells, and use of said reagent

Publication Date: 2023.08.08 KEIO UNIV

AI summary

A reagent for differentiating somatic cells into alveolar epithelial cells includes an NK2 homeobox family gene expression vector, and a Fox family gene expression vector, a method for manufacturing alveolar epithelial cells, the method including forcing a somatic cell to express an NK2 homeobox family gene and a Fox family gene and culturing the somatic cell after forced expression, an alveolar epithelial cell manufactured by the manufacturing method, and a cell medicine including the alveolar epithelial cell.